TAK-536
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for TAK-536, covering 2016-07-06 to 2024-12-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study of TAK-536 in Children From 2 to Less Than 6 Years Old With High Blood Pressure [Phase 3]